Tadagra 20 mg contains Tadalafil, a phosphodiesterase type 5 (PDE5) inhibitor used to treat erectile dysfunction. Since tadalafil is partly processed and eliminated by the kidneys, kidney function plays an important role in its safety and dosing.

Kidney function tests (such as serum creatinine and eGFR) should be checked before using Tadagra 20 mg in certain situations. These include individuals who already have a known history of chronic kidney disease (CKD), reduced urine output, or previous abnormal kidney test results. In such cases, the body may clear the medicine more slowly, increasing the risk of side effects like headache, dizziness, or low blood pressure.

Testing is also recommended for older adults (generally above 60–65 years), especially if they have other health conditions such as diabetes, hypertension, or heart disease. These conditions can silently affect kidney function over time.

Patients taking multiple long-term medications should also consider kidney testing before starting tadalafil, as drug interactions and reduced kidney clearance may affect safety.

Additionally, if a person experiences symptoms like swelling in the legs, fatigue, foamy urine, or changes in urination, kidney evaluation should be done before starting treatment.

In summary, kidney function tests should be considered before using Tadagra 20 mg in patients with known kidney disease, older age, chronic illnesses, or suspicious symptoms. This helps ensure safe dosing and reduces the risk of side effects during treatment.